Cristina Papayannidis, Ulf Schnetzke, Maximilian Fleischmann, Adolfo De La Fuente Burguera, Klaus Metzeler, Maureen Lane, Li Zhou, Ahmed Hamdy, Claudio Cerchione. "Preliminary pharmacokinetic and MRD results from AML patients treated with 7- and 14-day dosing schedule of emavusertib added to combination therapy with azacitidine and venetoclax." Blood, 2025. doi:10.1182/blood-2025-5201